logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
B

blood and lymphatic cancer: targets and therapy

IF
Papers21
Citations
Journal Papers 21
Publication Date
delete
Metabolic Subtypes Predict Treatment Response in Acute Myeloid Leukemia: A Pilot Study
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-06-16
delete0
deleteOAAI
deleteChangjian Yan; Yan Huang; Qing Cai; Xiang Li; Qinwen Yang; Gang Feng; Huilin Yang; Yanxin Chen; Jianda Hu
deleteShare
deleteSave
A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-05-22
delete0
deleteOAAI
deleteNa Zhao; Rong Chi; Kaidi Song; Yue Wu; Bingbing Yan; Dongyao Wang; Baolin Tang; Xiaoyu Zhu
deleteShare
deleteSave
Short-Term Longitudinal Analysis of Gut Microbiota Dynamics During Anti-CD19 CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma Patients
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-05-01
delete0
deleteOAAI
deleteZiyuan Shen; Xing Xing; Kang Rong; Ziyang Geng; Ning Yang; Linyan Xu; Hongfeng Ge; Wei Sang
deleteShare
deleteSave
Poor Outcome of Pediatric Patients with Acute Lymphoblastic Leukemia Harboring Low P16 Deletion Ratio: A Post-Hoc Analysis from a Prospective Cohort
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-04-30
delete0
deleteOAAI
deleteKun-Yin Qiu; Xiong-Yu Liao; Hai-Lei Chen; Hong Zheng; Jian-Pei Fang; Dun-Hua Zhou
deleteShare
deleteSave
Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-04-27
delete0
deleteOAAI
deleteMohammad Aljumaa; Hasan Hamam Refai; Yogesh Chawla; Wilson I Gonsalves
deleteShare
deleteSave
Enzymatic Laccase Nanoreactors Induce Apoptosis in MOLT-4-ALL Cells and Activate Prodrugs in a Synergetic Effect
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-04-27
delete0
deleteOAAI
deleteCarlos A Medrano-Villagómez; Elizabeth Loredo-García; Jahaziel Gasperin-Bulbarela; Rafael Vazquez-Duhalt
deleteShare
deleteSave
Prognostic Value of the Aggregate Inflammation Systemic Index (AISI) in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter Retrospective Study
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-03-31
delete0
deleteOAAI
deleteXicheng Chen; Linyu Huang; Qiming Zhang; Xing Xing; Shuo Zhang; Chunling Wang; Ling Wang; Ziyuan Shen; Wei Sang; On behalf of the Huaihai Lymphoma Working Group
deleteShare
deleteSave
Crosstalk Between FOXN3 and E2F5 Reveals a Novel Tumor Suppressive Pathway in Acute Myeloid Leukemia via MAPK Signaling: Implications for Potential Future Targeted Therapy
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-03-24
delete0
deleteOAAI
deleteJinjing Zhang; Qiao Jiang; Tong Liu; Hong Li; Ying Liang; Xianglan Lu; Hui Pang; Shibo Li; Yan Li; Rui Zhang
deleteShare
deleteSave
Health Disparities in Acute Myeloid Leukemia Patients Undergoing Treatment with Tyrosine Kinase Inhibitor (TKI) Therapy Targeting FLT3; IDH1; or IDH2
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-03-12
delete0
deleteOAAI
deleteManuel R Espinoza-Gutarra; Brooke A Jarrett; Xiaoliang Wang; Anosheh Afghahi; Sejong Bae
deleteShare
deleteSave
Construction and Validation of an N7-Methylguanosine–Related Prognostic Model for Acute Myeloid Leukemia
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-03-11
delete0
deleteOAAI
deleteLina Wang, Ming Li, Yaming Xi
deleteShare
deleteSave
Association Between Petroleum Compounds Exposure and Risk of Childhood Leukemia: A Systematic Review
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-02-11
delete0
deleteOAAI
deleteHossam Mohamed Hassan Soliman; Wesal Youssef Hassan; Marwa Mostafa; Mohamed Khamis Gomaa; Mohamed Hossam Soliman Jnr; Mohamed Fakhry Hussein
deleteShare
deleteSave
Natural Killer/T-Cell Lymphoma-Associated Hemophagocytic lymphohistiocytosis—a Rare and Dangerous Disease
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-01-27
delete0
deleteOAAI
deleteGuangqiang Meng; Manzhi Wang; Congcong Sun; Gege Feng; Jing Ren; Saran Feng; Yan Wang
deleteShare
deleteSave
Safety and Efficacy of Flumatinib in Patients with Chronic Phase Chronic Myeloid Leukemia: A Real-Life Cohort Observational Study
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-01-22
delete0
deleteOAAI
deleteFang Cheng; Zheng Cui; Qiang Li; Liu Wang; Weiming Li
deleteShare
deleteSave
Study on the Role of Neutrophil Extracellular Traps-Based Risk Model and Discriminative Gene LTF in the Prognosis of Acute Myeloid Leukemia and the Regulation of Immune Microenvironment
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-01-13
delete0
deleteOAAI
deleteYongjian Li; Jingru Zhang; Tingting Liu; Di Zhang; Nana Wang; Xiaomin Liu; Panpan Feng; Juan Zhang; Chunyan Ji; Jingjing Ye
deleteShare
deleteSave
Global Patterns; Temporal Trends; and Potential Non-Infectious Risk Factors for Burkitt Lymphoma from 1990 to 2021
deleteblood and lymphatic cancer: targets and therapy
IF0
delete2026-01-08
delete0
deleteOAAI
deleteShi-Kai Jin; Jun-Ting Lyu; Zi-Yu Feng; Shu-Qi Zhang; Bin-Yan Lu; Qin-Fu Yan; Jing Li; Jun Du; Zou-Fang Huang
deleteShare
deleteSave
Expression and Clinical Significance of BCL2 Interacting Protein 3 Like (BNIP3L) in Serum of Patients with MM
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-12-17
delete0
deleteOAAI
deleteYanyu Nong; Zengyi Xiong; Qicai Wang; Mengyuan Gu; Yanting Zheng; Yifan Wang; Jing Wu; Chunni Huang; Zhongqing Li; Jun Luo; Zhian Ling; Ruolin Li
deleteShare
deleteSave
LRG1 Drives AML Progression by Disrupting Myeloid Progenitor Regulation
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-12-17
delete0
deleteOAAI
deleteRongxia Guo; Peng Wu; Shuxin Yao; Fumei Liu
deleteShare
deleteSave
Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-12-12
delete0
deleteOAAI
deleteJianhua Chen; Qing Liao; Sha Yang; Jiaojiao Bian; Xianfu Li; Lu Zhao; Dan Wen; Dazhang Bai; Chunlei Yu; Chunyang Zhou; Zhengmin Xu
deleteShare
deleteSave
Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-12-06
delete0
deleteOAAI
deleteYajing Zhao; Xinguang Liu; Qiang He; Yafei Yu; Lei Xu; Caifeng Sun; Guoqiang Liu; Liang Wang; Ji Ma
deleteShare
deleteSave
Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia
deleteBlood and Lymphatic Cancer: Targets and Therapy
IF0
delete2025-11-05
delete0
deleteOAAI
deleteYutian Lei; Xiaoli Zhao; Huijun Huang; Limin Duan; Ji Xu; Kourong Miao; Huihui Zhao; Chun Qiao; Ming Hong; Sixuan Qian; Lei Fan; Yu Zhu
deleteShare
deleteSave